The government’s top vaccine official, working under Health Secretary Robert F. Kennedy Jr., restricted the approval of two ...

The FDA's Dr. Vinay Prasad said that he disagreed with the agency's career vaccine reviewers about COVID shot approvals.

An mRNA-based flu vaccine has the potential advantage to more precisely match circulating strains, support rapid response in a future influenza pandemic, and pave the way for COVID-19 combination ...

Moderna stock popped Wednesday after the CDC recommended the company's RSV vaccine for at-risk adults in their 50s.

Shares of Moderna MRNA rose nearly 6% yesterday after the U.S. Centers for Disease Control and Prevention (“CDC”) adopted new ...

Health Secretary Robert F. Kennedy Jr. endorsed the expanded use of RSV vaccines for people 50 through 59 years old who are ...

Following its acquisition by Supernus Pharmaceuticals, Sage Therapeutics has let go of all of its remaining workforce, which ...

Good morning, Chicago. Nearly 81 years to the date after 20-year-old Army Pfc. John L. Moore was wounded while fighting to liberate Europe during WWII, the Purple Heart he earned that day is now in ...

Vietnam trade deal helps support fresh record highs: Both the S&P 500 and Nasdaq pushed to new closing highs, in part thanks ...

The new memos from the Food and Drug Administration show how the agency’s vaccine chief, Dr. Vinay Prasad, personally ...